Abbvie Inc. vs Viatris Inc.
ABBV vs VTRS — side-by-side comparison from reported financials. ABBV leads 8, VTRS leads 4 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Viatris Inc.
VTRS · Healthcare
$17.64+1.15%Mixed
| Metric | ABBV | VTRS |
|---|---|---|
| Price | $276.43 | $17.64 |
| Market cap | $488B | $20.3B |
| Revenue (TTM) | $64.4B | $14.7B |
| Revenue growth | +1.8% | -4.2% |
| Net margin | 9.8% | -2.8% |
| Free cash flow | $18.2B | $1.95B |
| Net cash (debt) | ($56.2B) | ($11.2B) |
| 1-year price return | +19.8% | +76.6% |
| P/E | 77.4 | 5.5 |
| P/E vs own history (cheap-side %) | 23% | 9% |
| Dividend yield | 2.45% | 2.75% |
| Return on equity | 96% | -3% |
| Altman Z-score | 2.33 | 0.99 |
| CV checks passed | 9 of 11 | 6 of 11 |
| Employees | 57,000 | 30,000 |
Full résumé-style profiles: ABBV CV · VTRS CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.